Kite, a Gilead Company (Nasdaq: GILD), today announced plans to expand its global cell therapy supply chain operations in Frederick County. This year, the California-based company will begin construction on an approximately 70,000 square-foot centralized raw materials warehouse that will serve Kite’s global manufacturing network and will be located adjacent to its existing facility in the Urbana Corporate Center. The expansion will bring an additional 100 jobs to the area, with the company expecting to employ more than 500 full-time staff between its two facilities by the end of 2026.
“As the global leader in cell therapy, it is important to continue to streamline our manufacturing processes to meet the needs of people living with difficult-to-treat blood cancers. Centralizing our raw materials storage and testing will enable us to bring control of materials in-house to increase the speed and efficiency of our global manufacturing operations so we can continue to grow to meet patient demand,” said Chris McDonald, SVP & global head of technical operations, Kite. “Additionally, by locating these global operations in Maryland, we can serve both our European and California manufacturing operations in the same day. With three major airports in the area, we have increased flexibility in receiving and shipping materials, which is critical for patients who are waiting for our therapies.”